No revenue reported as clinical programs remain in precommercial stages. Workforce and cost reductions are expected to extend cash runway into the fourth quarter of 2026. Adicet Bio (NASDAQ:ACET), a ...

More than two dozen At Home stores are set to close by the end of September as the company continues to deal with dwindling sales and crippling debt.